Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins

Pharmaceutical compositions and methods for fabrication of solid masses comprising anti-interleukin antibodies

Pharmaceutical formulations of a HIF hydroxylase inhibitor

Controlled Release Dosage Form for Once Daily Administration of Dimethyl Fumarate

Stable orally disintegrating pharmaceutical compositions

LACOSAMIDE CONTROLLED RELEASE FORMULATION

COMPRESSION-MOLDED PREPARATION

Solid Oral Formulations and Crystalline Forms of an Inhibitor of Apoptosis Protein

PHARMACEUTICAL COMPOSITION

Neridronic acid for treating complex regional pain syndrome

Beta-lactamase formulations and uses thereof

CONTROLLED RELEASE HYDROCODONE FORMULATIONS

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INDOLEAMINE, 2, 3-DIOXYGENASE INHIBITION AND INDICATIONS THEREFOR

Substituted oxopyridine derivatives

ANTIDIABETIC MEDICATIONS

PHARMACEUTICAL COMPOSITIONS

SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE

Proliferous copolymers comprising lactamic moieties

POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS

Implantable Naltrexone tablets

FORMULATIONS FOR DELIVERING INSULIN

FIXED DOSE FORMULATIONS

Methods and compositions for self-regulated release of active pharmaceutical ingredient

PHARMACEUTICAL COMPOSITIONS

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

GEMCABENE COMBINATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE

Methods for the treatment of abnormal involuntary movement disorders

Controlled release and taste masking oral pharmaceutical composition

Directly compressible composition comprising microcrystalline cellulose

Pharmaceutical Composition Comprising Deferasirox

Oral formulations of pyrrolidine derivatives

ORAL PHARMACEUTICAL COMPOSITION COMPRISING OTILONIUM BROMIDE AND SIMETHICONE WITH CERTAIN BULK DENSITY AND IMPROVED DISSOLUTION CHARACTERISTICS

Pharmaceutical composition containing clomipramine and preparation method therefor

Solid forms and methods of preparing the same

Oral drug dosage forms having desired drug release profiles and uses thereof

Optimized high-dose mesalazine-containing tablet

Pharmaceutical compositions of compound

METHOD OF TREATING HYPERTENSION

SYNERGISTIC USE OF CANNABIS FOR TREATING MULTIPLE MYELOMA

ENHANCED ABUSE-DETERRENT FORMULATIONS OF OXYCODONE

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

PHARMACEUTICAL COMPOSITION FOR PROMOTING PERIODONTAL TISSUE GROWTH AND FOR PREVENTION AND TREATMENT OF PERIODONTITIS, CONTAINING MAGNOLIA FLOWER EXTRACT, FRACTION THEREOF OR COMPOUND ISOLATED THEREFROM AS ACTIVE INGREDIENT

Pharmaceutical composition containing an arylalkylamine compound

Rapidly Dispersible Dosage Form with High Drug Content

DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION

USE OF CANNABIS TO TREAT MIGRAINE

Solid oral dosage forms of eslicarbazepine

Composite granulated product including sugar or sugar alcohol, swelling binder, disintegrating agent and highly absorbent excipient, and method for manufacturing composite granulated product

Pharmaceutical preparation comprising phenylalanine derivative

CHOLESTYRAMINE PELLETS AND METHODS FOR PREPARATION THEREOF

Cholestyramine pellets and methods for preparation thereof

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

Modified release multi-layer tablet cannabinoid formulations

Oral particulate composition

MAGNESIUM-CONTAINING PRODUCTS AND USES THEREOF

Pregabalin-containing, high swellable, sustained-release triple layer tablet

Pharmaceutical compositions of linagliptin and process for preparation thereof

Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor

TABLETS HAVING MEDIA INDEPENDENT ACTIVE SUBSTANCE DELIVERY

Pharmaceutical composition containing 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereof

Antibacterial compositions of a beta-lactamase inhibitor with a cephalosporin

GRANULATE FORMULATION OF 5-METHYL-1-PHENYL-2-(1H)-PYRIDONE AND METHOD OF MAKING THE SAME

ABUSE-PROOFED DOSAGE FORM

Pharmaceutical compositions containing a DGAT1 inhibitor

Formulation and treatment methods

Pharmaceutical compositions comprising Afatinib

Salts of active ingredients with polymeric counterions

FIXED-DOSE COMBINATIONS OF ANTIVIRAL COMPOUNDS

FIXED-DOSE COMBINATIONS OF ANTIVIRAL COMPOUNDS

Gastro-resistant formulation containing posaconazole

Modified release compositions comprising tacrolimus

ORAL FORMULATIONS OF DEFERASIROX

Solid dispersions comprising tacrolimus

IMMEDIATE RELEASE CANNABINOID FORMULATIONS

Pressurized metered dose inhalers and method of manufacture

DUAL USE ORAL PHARMACEUTICAL COMPOSITION TABLETS OF SULFATE SALTS AND METHODS OF USE THEREOF

GABA ANALOG PRODRUG SUSTAINED RELEASE ORAL DOSAGE FORMS

Pulverulent, directly compressible polyvinyl alcohol grades

Solid dosage forms of palbociclib

MULTIPLE PILL ABUSE-RESISTANT IMMEDIATE RELEASE SOLID DOSAGE FORM OF HYDROCODONE

Immediate release abuse-deterrent granulated dosage forms

ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM

ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS

Mirabegron-containing tablet, method for producing mirabegron-containing pharmaceutical preparation, and method for producing mirabegron-containing granulated product

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

TRIPULSE RELEASE STIMULANT FORMULATIONS

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

RAPID DISSOLVE TABLET COMPOSITIONS FOR VAGINAL ADMINISTRATION

ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM

Orodispersible dosage unit containing an estetrol component

PAC-1 combination therapy

PHARMACEUTICAL COMPOSITION

Sustained release formulation and tablets prepared therefrom

PHARMACEUTICAL COMPOSITIONS

Solid Dispersion Comprising μ-Opioid Antagonists

Oral solid formulation containing irinotecan and method of preparing the same

Tamper resistant dosage forms

Tamper resistant dosage forms

Single layer oral dose of neuro-attenuating ketamine

ALCOHOL RESISTANT DOSAGE FORMS

Pharmaceutical composition of MEK inhibitor and preparation method thereof

RAPID DISSOLVE TABLET COMPOSITIONS FOR VAGINAL ADMINISTRATION

Pharmaceutical Formulation Containing Gelling Agent

ABUSE-PROOFED ORAL DOSAGE FORM

IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONE

Treatment of NASH with Gemcabene

Pharmaceutical Formulation Containing Gelling Agent

Position-Specific Asymmetric Deuterium Enriched Catecholamine Derivatives And Medicaments Comprising Said Compounds

COMPOSITIONS AND METHODS OF USING (R)-PRAMIPEXOLE

ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS

Modified release preparations containing oxcarbazepine and derivatives thereof

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

MUCOADHESIVE DEVICES FOR DELIVERY OF ACTIVE AGENTS

Mesalamine for the treatment of cancer

SUBSTITUTED N-([1,1'-BIPHENYL]-3-YL)-[1,1'-BIPHENYL]-3-CARBOXAMIDE ANALOGS AS INHIBITORS FOR BETA-CATENIN/B-CELL LYMPHOMA 9 INTERACTIONS

Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto

COMPOSITIONS AND METHODS FOR TREATING MIDDLE-OF-THE-NIGHT INSOMNIA

Ribociclib tablet

ANTI-OVERINGESTION DOSAGE FORMS

TABLETED COMPOSITIONS CONTAINING ATAZANAVIR

ORAL FORMULATIONS OF DEFERASIROX

Copolymers as excipients for effective solubilization of poorly water-soluble substances from solid mixtures

MAGNESIUM-CONTAINING PRODUCTS AND USES THEREOF

Tablet compositions

Methods for the treatment of abnormal involuntary movement disorders

Pharmaceutical compositions comprising Akt protein kinase inhibitors

Pharmaceutical formulation containing gelling agent

Non-bleeding bioactive natural pigments which prevent color and dust explosions, method of preparation thereof

Pharmaceutical compositions

NOVEL COMPOSITION FOR TREATMENT OF ESSENTIAL THROMBOCYTHEMIA

ABUSE DETERRENT COMPOSITIONS AND METHODS OF MAKING SAME

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

IMMEADIATE RELEASE ORAL TABLET

PHARMACEUTICAL FORMULATION CONTAINING OPIOID AGONIST, OPIOID ANTAGONIST AND GELLING AGENT

Pharmaceutical formulation containing gelling agent

Method of producing a granulated composition

Pharmaceutical Compositions Comprising Ledipasvir And Sofosbuvir

Oral pharmacological composition including 5-{4-(amino sulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2H)-furanone having crystalline structure with excellent stability

TABLET CONTAINING FERRIC CITRATE

MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES

Drug delivery system to increase bioavailability

STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ANTIBACTERIAL AGENT

DISPERSIBLE COMPOSITIONS

MODIFIED RELEASE COMPOSITIONS OF EPALRESTAT OR A DERIVATIVE THEREOF AND METHODS FOR USING THE SAME

Pharmaceutical compositions for colon-specific delivery

Oral disintegrating tablet

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES

Pharmaceutical tablet for use in administering one or more pharmaceutically active ingredients

Combination formulation of three antiviral compounds

Method for treating cancer

PHARMACEUTICAL COMPOSITIONS

Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders

ANTICANCER COMPOSITIONS

Stable orally disintegrating pharmaceutical compositions

Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods

Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent

Drug delivery system

Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia and cardiovascular diseases

Solid pharmaceutical compositions containing pregabalin

PHARMACEUTICAL COMPOSITIONS

PHARMACEUTICAL COMPOSITIONS

Pharmaceutical compositions

Treatment of hepatitis C using histone deacetylase inhibitors

Oxycodone formulations

Oral Tablet Formulation Consisting Of Fixed Combination Of Rosuvastatin And Ezetimibe For Treatment Of Hyperlipidemia And Cardiovascular Diseases

FORMULATIONS OF RIFAXIMIN AND USES THEREOF

INHIBITING BLOOD PRESSURE DROP IN THE TREATMENT OF ERECTILE DYSFUNCTION

Substituted pyrimidines for treatment of chronic cough, neuronal hypersensitivity underlying chronic cough, neuronal hypersensitivity underlying sub-acute cough and neuronal hypersensitivity underlying acute cough

Methods for the treatment of abnormal involuntary movement disorders

Solid pharmaceutical composition comprising amlodipine and losartan

METHOD OF TREATING HYPERTENSION

METHODS AND COMPOSITION FOR TREATMENT OF CARDIOVASCULAR CONDITIONS

CENICRIVIROC COMBINATION THERAPY FOR THE TREATMENT OF FIBROSIS

COMPOSITIONS AND METHODS OF PROVIDING THYROID HORMONE OR ANALOGS THEREOF

INGESTIBLE FORMULATIONS FOR TRANSIENT, NONINVASIVE REDUCTION OF GASTRIC VOLUME

DPP IV INHIBITOR FORMULATIONS

PHARMACEUTICAL DOSAGE FORMS

EXTENDED RELEASE FORMULATIONS OF FLURBIPROFEN AND TRAMADOL

Controlled release and taste masking oral pharmaceutical compositions

Controlled release and taste masking oral pharmaceutical compositions

Formulations of an LSD1 inhibitor

Opioid receptor modulator dosage formulations

PHARMACEUTICAL CAPSULE CONTAINING AT LEAST TWO TABLETS

Controlled release and taste masking oral pharmaceutical composition

A SUSTAINED-RELEASE FORMULATION OF METFORMIN AND A PREPARATION METHOD THEREOF

ORALLY DISINTEGRATING TABLET AND METHOD FOR PRODUCING SAME

Crystalline solid state form of the benzene sulphonic acid salt of 2-[(4S)-6-(4-chlorophenyl)-1-methyl-8-(methyloxy)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide

Tamper resistant pharmaceutical formulations

COMPOSITIONS FOR CONTROL OF DRUG ABUSE

TWO SPEED MONOLOTHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS

Granulate formulation of 5-methyl-1-phenyl-2-(1H)-pyridone and method of making the same

Misoprostol Dispersible Tablet

Modified release formulations containing drug-ion exchange resin complexes

Antidiabetic Solid Pharmaceutical Compositions

MAO-B INHIBITORS AND REHABILITATION

EXTENDED RELEASE PHARMACEUTICAL FORMULATIONS

Mangiferin-6-O-berberine salt and preparation method and use thereof

METHOD OF ADMINISTERING DIVALPROEX

Pharmaceutical compositions for N-propargylamine derivative

Compositions and methods for reducing overdose

Pharmaceutical Compositions for Colon-Specific Delivery

Methods of treating depression using orexin-2 receptor antagonists

Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor

MEDICINE

Methods and compositions for self-regulated release of active pharmaceutical ingredient

PHARMACEUTICAL COMBINATIONS OF SITAGLIPTIN

Pharmaceutical tablet for use in administering nicotine

Pregabalin sustained-release preparation

Pharmaceutical dosage form for immediate release of an indolinone derivative

Tablet formulation of 2-fluoro-N-methyl-4-[ 7-( quinolin-6-ylmethyl) imidazo [1,2-B] [1,2,4] triazin-2-yl] benzamide

Pharmaceutical Compositions of Edoxaban

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

COMPACTED SOLID DOSAGE FORM

Cholestyramine pellets and methods for preparation thereof

Conformal coating of cells for immunoisolation

Oral formulation of A-nor-5α androstane compound

Tamper resistant pharmaceutical formulations

DIRECTLY COMPRESSIBLE POLYVINYL ALCOHOLS

Directly compressible composition comprising microcrystalline cellulose

Polyvinyl alcohol particles, pharmaceutical binder using same, pharmaceutical tablet, sustained-release pharmaceutical tablet, and method for producing polyvinyl alcohol particles

Combination formulation of two antiviral compounds

PEDIATRIC CHEWABLE TABLET CONTAINING ANTIVIRAL AGENT AND METHOD FOR THE PREPARATION THEREOF

Method of treating colorectal cancer by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)pheny1)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl) carbamate

PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE 5 RECEPTOR (MGLU5) ANTAGONISTS

DUAL DRUG DOSAGE FORMS WITH IMPROVED SEPARATION OF DRUGS

Water dispersible mini-tablets comprising Enalapril for treatment of hypertension in a pediatric population and method of preparation thereof

Treatment of hepatitis C using histone deacetylase inhibitors

Derivatives of 7-fluoro-8-chloro-5H-dibenzo [B,E,] [1,4] diazepine and use thereof

MUCOADHESIVE DEVICES FOR DELIVERY OF ACTIVE AGENTS

PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL-2 FAMILY INHIBITOR

SOLID DOSAGE FORMS

Solid oral formulation of fenretinide

ABUSE DETERRENT IMMEDIATE RELEASE BIPHASIC MATRIX SOLID DOSAGE FORM

High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms

Formulations of pyrimidinedione derivative compounds

Misoprostol dispersible tablet

Pharmaceutical formulations of a pan-RAF kinase inhibitor and processes for their preparation

ANTIDIABETIC MEDICATIONS

IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONE

ORALLY DISSOLVING FORMULATIONS OF MEMANTINE

Rapidly dispersible dosage form of oxcarbazepine

SUSTAINED RELEASE DRUG DELIVERY SYSTEM

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS

THREE-PHASE CONTROLLED-RELEASE TABLET COMPRISING MELATONIN AND PROCESS OF PREPARATION

ORAL DOSAGE FORM COMPRISING TRI-SUBSTITUTED GLYCEROL COMPOUNDS

Method of treating hypertension

Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent

Clopidogrel Hydrogen Sulfate Solid Preparation and Its Preparation Method

ALLISARTAN ISOPROXIL SOLID DISPERSION AND PHARMACEUTICAL COMPOSITION

Pharmaceutical formulation comprising losartan potassium and chlorthalidone

Abuse deterrent immediate release coated reservoir solid dosage form

A NOVEL PHARMACEUTICAL COMPOSITION OF SOFOSBUVIR AND RIBAVIRIN

Pharmaceutical preparation for masked taste oral administration, containing clomipramine

Methods of manufacturing oral formulations

COMPOSITIONS FOR ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING LOW BACK PAIN

Controlled release and taste masking oral pharmaceutical compositions

Extended release, abuse deterrent pharmaceutical compositions

Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders

Immediate release abuse-deterrent granulated dosage forms

Methods and compositions for deterring abuse

Solid Pharmaceutical Compositions Containing Pregabalin

SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR

Methods of manufacturing oral dosage forms

Methods of treating opiate dependency and preventing non-oral opiate abuse among opiate addicts

ALLISARTAN ISOPROXIL SOLID DISPERSION AND PHARMACEUTICAL COMPOSITION

MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF SOFOSBUVIR AND RIBAVIRIN

Tamper resistant dosage forms

Tamper resistant dosage forms

Tamper resistant dosage forms

Tamper resistant dosage forms

DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation

Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compounds

EXTENDED RELEASE COMPOSITIONS OF CARVEDILOL PHOSPHATE

2,5-DISUBSTITUTED CYCLOPENTANE CARBOXYLIC ACIDS FOR THE TREATMENT OF RESPIRATORY TRACT DISEASES

Pharmaceutical composition comprising licarbazepine acetate

CERITINIB FORMULATION

Amorphous solid dispersion comprising taxane, tablet comprising the same, and method for preparing the same

DIRECTLY COMPRESSIBLE GRANULAR MICROCRYSTALLINE CELLULOSE BASED EXCIPIENT, MANUFACTURING PROCESS AND USE THEREOF

TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION

Pharmaceutical formulation containing gelling agent

MEDICAMENTS, USES AND METHODS

Pharmaceutical compositions comprising ferric citrate and methods for the production thereof

Solid dispersions of insoluble drug and preparation method thereof

Modified release formulations containing drug-ion exchange resin complexes

Pharmaceutical compositions

Pharmaceutical composition comprising a triazole antifungal agent and method for preparation thereof

Use of selectively moisture-adjusted tabletting material in the production of mechanically stable tablets which contain at least one hydrate-forming active substance and/or adjuvant relevant to the mechanical stability of the tablets, particularly arginine-containing tablets

ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER, AN AGENT THAT PREVENTS GAS RETENTION, AND DIGESTIVE ENZYMES, AND PREPARATION METHOD THEREOF

Method and composition for the treatment of opioid induced constipation

FORMULATIONS PHARMACOKINETICS OF DEUTERATED BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2

Pharmaceutical composition and administrations thereof

Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein

Sublingual delivery of glatiramer acetate

STABLE PHARMACEUTICAL COMPOSITIONS OF SOFOSBUVIR

Process for drying of BIBW2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient

Compositions and methods for reducing overdose

ALCOHOL RESISTANT DOSAGE FORMS

Controlled release and taste masking oral pharmaceutical composition

Solid pharmaceutical preparations containing copolymers based on polyethers combined with poorly water-soluble polymers